These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 25792807)

  • 21. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant.
    Thanos S; Naskar R
    Exp Eye Res; 2004 Jul; 79(1):119-29. PubMed ID: 15183107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation.
    Schwartz M; London A
    Prog Brain Res; 2008; 173():375-84. PubMed ID: 18929122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
    Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
    Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potentials of aspirin in glaucomatous optic neuropathy.
    Attarzadeh A; Hosseini H; Nowroozizadeh S
    Med Hypotheses; 2006; 67(2):375-7. PubMed ID: 16527427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding Glaucomatous Optic Neuropathy: The Synergy Between Clinical Observation and Investigation.
    Quigley HA
    Annu Rev Vis Sci; 2016 Oct; 2():235-254. PubMed ID: 28532352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotection in glaucoma - Is there a future role?
    Baltmr A; Duggan J; Nizari S; Salt TE; Cordeiro MF
    Exp Eye Res; 2010 Nov; 91(5):554-66. PubMed ID: 20800593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotection in Glaucoma: Animal Models and Clinical Trials.
    Almasieh M; Levin LA
    Annu Rev Vis Sci; 2017 Sep; 3():91-120. PubMed ID: 28731838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotection in the treatment of glaucoma--A focus on connexin43 gap junction channel blockers.
    Chen YS; Green CR; Danesh-Meyer HV; Rupenthal ID
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):182-93. PubMed ID: 25676338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy.
    Levin LA
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S98-101. PubMed ID: 10416753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotection in glaucoma--delusion, reality or hope?
    Dimovska-Jordanova A
    Prilozi; 2012; 33(2):163-73. PubMed ID: 23425879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is neuroprotection a viable therapy for glaucoma?
    Weinreb RN; Levin LA
    Arch Ophthalmol; 1999 Nov; 117(11):1540-4. PubMed ID: 10565524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into blindness; mechanical fatigue of optic nerve head in glaucomatous optic neuropathy.
    Norouzpour A; Mehdizadeh A
    J Med Eng Technol; 2014 Oct; 38(7):367-71. PubMed ID: 25188359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current understanding of neuroprotection in glaucoma.
    Wein FB; Levin LA
    Curr Opin Ophthalmol; 2002 Apr; 13(2):61-7. PubMed ID: 11880717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
    Hartwick AT
    Optom Vis Sci; 2001 Feb; 78(2):85-94. PubMed ID: 11265931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiglaucoma pharmacotherapy.
    Tătaru CP; Purcărea VL
    J Med Life; 2012 Sep; 5(3):247-51. PubMed ID: 23049625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma.
    Neufeld AH
    Brain Res Bull; 2004 Feb; 62(6):455-9. PubMed ID: 15036557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The arguments for and against cannabinoids application in glaucomatous retinopathy.
    Panahi Y; Manayi A; Nikan M; Vazirian M
    Biomed Pharmacother; 2017 Feb; 86():620-627. PubMed ID: 28027538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
    Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some current ideas on the pathogenesis and the role of neuroprotection in glaucomatous optic neuropathy.
    Osborne NN; Chidlow G; Wood J; Casson R
    Eur J Ophthalmol; 2003 Apr; 13 Suppl 3():S19-26. PubMed ID: 12749673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In glaucoma, should enthusiasm about neuroprotection be tempered by the experience obtained in other neurodegenerative disorders?
    Haefliger IO; Fleischhauer JC; Flammer J
    Eye (Lond); 2000 Jun; 14 ( Pt 3B)():464-72. PubMed ID: 11026975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.